SCHEMBL17073496

SCHEMBL17073496

CNC(CCC1CC1)c1ccc(F)c(N)c1

nearest known ligand 0.31

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 1/20 0.30
ADRA2A P08913 1/20 0.30
ADRB3 P13945 1/20 0.30
ADRA2B P18089 1/20 0.30
ADRA2C P18825 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28234853 0.83
SCHEMBL20584678 0.82
SCHEMBL31456852 0.82
SCHEMBL20584679 0.82
SCHEMBL31067442 0.82
SCHEMBL17064413 0.82
SCHEMBL20584680 0.82
SCHEMBL17064475 0.78 ADRB1 (0.35) ADRB1ADRA2AADRB3ADRA2BADRA2C
SCHEMBL25805122 0.78
SCHEMBL17064402 0.77 DUT (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015134998-A1 HUMAN PLASMA KALLIKREIN INHIBITORS BIOCRYST PHARMACEUTICALS, INC. (US) 2015-09-11 WO disclosed